Eteplirsen for treating Duchenne muscular dystrophy [ID1003]
In development [GID-HST10007] Expected publication date: TBC
Search results
72 results
-
-
Peezy Midstream for urine collection (MT446)
In development [GID-MT538] Expected publication date: TBC
-
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]
In development [GID-HST10037] Expected publication date: TBC
-
Stroke rehabilitation in adults
In development [GID-NG10175] Expected publication date: 18 October 2023
-
Weight Management: preventing, assessing and managing overweight and obesity (update)
In development [GID-NG10182] Expected publication date: 22 June 2023
-
Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]
In development [GID-HST10004] Expected publication date: TBC
-
SpaceOAR hydrogel spacer for reducing rectal toxicity during radiotherapy for prostate cancer (Suspended – referred to technology appraisals)
In development [GID-MT526] Expected publication date: TBC
-
GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain
In development [GID-MT567] Expected publication date: TBC
-
Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]
In development [GID-HST10050] Expected publication date: TBC
-
Osteoporosis: assessing the risk of fragility fracture
In development [GID-NG10216] Expected publication date: 21 February 2024
-
GID-MT557 Novii Wireless Patch System for maternal and fetal monitoring (MT509)
In development [GID-MT557] Expected publication date: TBC
-
Afamelanotide for treating erythropoietic protoporphyria [ID927]
In development [GID-HST10009] Expected publication date: TBC
-
Palovarotene for treating flare ups of heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID2721]
In development [GID-HST10033] Expected publication date: TBC
-
Head injury: assessment and early management
In development [GID-NG10164] Expected publication date: 23 February 2023
-
Memokath-051 stent for ureteric obstruction
In development [GID-MT569] Expected publication date: 07 December 2022
-
Sebelipase alfa for treating Wolman disease [ID3995]
In development [GID-HST10047] Expected publication date: TBC
-
Maternal and child nutrition
In development [GID-NG10191] Expected publication date: 22 November 2023
-
Rehabilitation for chronic neurological disorders including acquired brain injury
In development [GID-NG10181] Expected publication date: 13 December 2023
-
Subarachnoid haemorrhage due to ruptured aneurysms
In development [GID-NG10097] Expected publication date: TBC
-
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (review of HST3) ID1642
In development [GID-HST10044] Expected publication date: 25 January 2023
-
Lysosomal acid lipase deficiency - sebelipase alfa [ID737]
In development [GID-LYSOSOMALACIDLIPASEDEFICIENCYSEBELIPASEALFAID737] Expected publication date: TBC
-
Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]
In development [GID-HST10038] Expected publication date: TBC
-
Diabetic foot problems: prevention and management (update)
In development [GID-NG10285] Expected publication date: 18 January 2023
-
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency [ID3791]
In development [GID-HST10052] Expected publication date: 29 March 2023
-
Falls in older people: assessing risk and prevention
In development [GID-NG10228] Expected publication date: 13 June 2024
-
GID-MT564 GreenLight XPS for treating benign prostatic hyperplasia
In development [GID-MT564] Expected publication date: 14 October 2022
-
GID-MT565 Optilume for recurrent bulbar urethral strictures
In development [GID-MT565] Expected publication date: 28 November 2022
-
GID-MT570 AposHealth for osteoarthritis (OA) of the knee
In development [GID-MT570] Expected publication date: 31 March 2023
-
GID-MT562 FibroScan for assessing liver fibrosis and cirrhosis in primary or community care
In development [GID-MT562] Expected publication date: 21 December 2022
-
Urinary tract infection in under 16s: diagnosis and management
In development [GID-NG10259] Expected publication date: 27 July 2022
-
Obesity: identification and classification of overweight and obesity (update)
In development [GID-NG10284] Expected publication date: 08 September 2022
-
Delirium: prevention, diagnosis and management
In development [GID-NG10332] Expected publication date: 11 January 2023
-
Cardiovascular disease: risk assessment and reduction, including lipid modification
In development [GID-NG10178] Expected publication date: 19 April 2023
-
Diabetic retinopathy
In development [GID-NG10256] Expected publication date: 03 April 2024
-
Thyroid cancer: assessment and management
In development [GID-NG10150] Expected publication date: 19 December 2022
-
GID-MT568 Magtrace and Sentimag for locating sentinel lymph nodes
In development [GID-MT568] Expected publication date: 05 October 2022
-
Cirrhosis in over 16s: assessment and management
In development [GID-NG10355] Expected publication date: 07 February 2024
-
Harmful gambling: identification, assessment and management
In development [GID-NG10210] Expected publication date: 07 February 2024
-
Hip fracture: management (update)
In development [GID-NG10280] Expected publication date: TBC
-
Setmelanotide for treating obesity caused by LEPR or POMC deficiency [ID3764]
In development [GID-HST10034] Expected publication date: 20 July 2022
-
GID-MT564 GreenLight XPS for treating benign prostatic hyperplasia: draft guidance
We are listening to your views on this Medical technologies guidance. Comments close 13 July 2022.
-
Osteoarthritis: care and management (update)
In development [GID-NG10127] Expected publication date: 19 October 2022
-
Breast cancer – reducing arm and shoulder mobility problems after breast cancer surgery (update)
In development [GID-NG10354] Expected publication date: TBC
-
GID-MT566 Faecal microbiota transplant for recurrent Clostridioides difficile infection
In development [GID-MT566] Expected publication date: 30 August 2022
-
Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management
In development [GID-NG10165] Expected publication date: 23 January 2023
-
Onasemnogene abeparvovec for treating pre-symptomatic spinal muscular atrophy (MAA partial review of HST 15) [ID4051]
In development [GID-HST10053] Expected publication date: 25 May 2023
-
Asthma: diagnosis, monitoring and chronic asthma management
In development [GID-NG10186] Expected publication date: 15 November 2023
-
Ovarian cancer: identifying and managing familial and genetic risk
In development [GID-NG10225] Expected publication date: 13 March 2024
-
Atopic Dermatitis (Eczema)
In development [GID-NG10289] Expected publication date: TBC
-
GID-MT565 Optilume for recurrent bulbar urethral strictures: draft guidance
We are listening to your views on this Medical technologies guidance. Comments close 12 July 2022.